The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination.
A case is reported of a woman who was exposed to human immunodeficiency virus through self-insemination. She was artificially inseminated with fresh semen obtained from a gay man in whom HIV seroconversion was taking place. Postexposure prophylaxis with antiretrovirals was initiated 10 days later, and despite successful conception, HIV infection was not established. A healthy male infant was subsequently delivered with no obvious toxicity related to medication.
Bloch
M
M
Carr
A
A
Vasak
E
E
Cunningham
P
P
Smith
D
D
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission*; D006679:HIV Seropositivity; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D007316:Insemination, Artificial, Heterologous; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D011247:Pregnancy; D014019:Tissue Donors; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir